Lates News

Every AI express news, Pacific Securities released a research report on November 9, giving a "buy" rating to Vivalife Medical (688016.SH). The rating reasons mainly include: 1) rapid growth of overseas business, continuous promotion and expansion provide strong growth momentum; 2) research and development results are gradually realized, with sufficient reserve for future growth momentum; 3) The gross profit margin is affected by product price reductions and the expense ratio is rising. (Daily Economic News)